These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23537191)

  • 1. Inhaler devices for patients with COPD.
    Fink JB; Colice GL; Hodder R
    COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Customizing inhaled therapy to meet the needs of COPD patients.
    Fromer L; Goodwin E; Walsh J
    Postgrad Med; 2010 Mar; 122(2):83-93. PubMed ID: 20203459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Cavalli F; Usmani OS; Rogliani P
    Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
    [No Abstract]   [Full Text] [Related]  

  • 6. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
    Ding B; Small M; Scheffel G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Pepper AN; Cooke A; Livingston L; Lockey RF
    Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
    Molimard M; Till D; Stenglein S; Singh D; Krummen M
    Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing drug delivery in COPD: The role of inhaler devices.
    Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
    Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device errors in asthma and COPD: systematic literature review and meta-analysis.
    Chrystyn H; van der Palen J; Sharma R; Barnes N; Delafont B; Mahajan A; Thomas M
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):22. PubMed ID: 28373682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat Soft Mist inhaler: results of phase II single-dose crossover studies.
    Koehler D; Pavia D; Dewberry H; Hodder R
    Respiration; 2004; 71(5):469-76. PubMed ID: 15467324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
    Dolovich MB; Ahrens RC; Hess DR; Anderson P; Dhand R; Rau JL; Smaldone GC; Guyatt G; ;
    Chest; 2005 Jan; 127(1):335-71. PubMed ID: 15654001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nebulized therapy in the management of COPD: evidence and recommendations.
    Dhand R; Dolovich M; Chipps B; Myers TR; Restrepo R; Farrar JR
    COPD; 2012 Feb; 9(1):58-72. PubMed ID: 22292598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of dry powder inhalers in COPD.
    Wilson DS; Gillion MS; Rees PJ
    Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease.
    Ram FS; Brocklebank DM; Muers M; Wright J; Jones PW
    Cochrane Database Syst Rev; 2002; 2002(1):CD002170. PubMed ID: 11869627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol Delivery Devices for Obstructive Lung Diseases.
    Pleasants RA; Hess DR
    Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
    Barrons R; Pegram A; Borries A
    Am J Health Syst Pharm; 2011 Jul; 68(13):1221-32. PubMed ID: 21690428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.